Orthofix Medical
OFIX
178 hedge funds and large institutions have $1.01B invested in Orthofix Medical in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 13 closing their positions.
123% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 13
16% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 57
9% more funds holding
Funds holding: 164 → 178 (+14)
6% more capital invested
Capital invested by funds: $954M → $1.01B (+$59.7M)
2.08% less ownership
Funds ownership: 95.76% → 93.69% (-2.1%)
12% less call options, than puts
Call options by funds: $1.16M | Put options by funds: $1.32M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$10.9M |
| 2 |
BlackRock
New York
|
+$10.6M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.72M |
| 4 |
Renaissance Technologies
New York
|
+$5.48M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$5.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$27.4M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$12.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.66M |
| 4 |
JP Morgan Chase
New York
|
-$7.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.93M |
OFIX Hedge Fund Activity: Q1 2018 in Review
178 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q1 2018, worth a combined $1.01B — up 6.3% from $954M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new OFIX positions and 13 closed out — a net gain of 16 holders — while 66 added to existing stakes and 57 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $10.9M. The largest seller was Camber Capital Management, exiting entirely with an estimated $27.4M sold.
- 178 institutional investors held Orthofix Medical (OFIX) as of Q1 2018, up from 164 in Q4 2017.
- Funds reported $1.01B of Orthofix Medical stock for Q1 2018, up 6.3% quarter-over-quarter.
- 29 funds opened new Orthofix Medical positions in Q1 2018 and 13 closed out, a net change of +16 holders.
- The largest Orthofix Medical buyer in Q1 2018 was Arrowstreet Capital, an estimated $10.9M added.
- The largest Orthofix Medical seller in Q1 2018 was Camber Capital Management, an estimated $27.4M sold.
Based on aggregated 13F filings for Q1 2018.